PHARMACEUTICAL COMPANY
Endpoint Ground Zero: Multi-Method Malware and Ransomeware Prevention
Company Profile:
Rapidly growing specialty pharmaceutical company headquartered in Southern California
Challenges:
- Prevent continuous malware and ransomware threats against company’s endpoints and network hosts.
- Legacy Anti-Virus ineffective against unknown threats and exploits while also creating network latency with VDI environment.
- Unsupported and un-patchable operating systems running legacy medical applications creating vulnerabilities with Windows and Linux server environment.
Solution:
Deployed EndPoint Armor’s Advanced EndPoint Protection managed service, powered by Palo Alto Networks Traps
Minimize endpoint infections by blocking malware, exploits and ransomware with multi-method prevention: WildFire threat intelligence, local analysis via machine learning, pre-exploit and technique-based exploit protection
Replaced legacy and ineffective AV
Fully integrated with EndPoint Armor’s 24×7 ongoing support & management
Includes all necessary subscription licensing and support costs in one cost-effective monthly subscription expense.
Results:
- Stopped 100% of ransomware samples tested on multiple endpoints and operating systems during proof of concept
- Traps multi-method prevention techniques blocks known/unknown malware and exploits while delivering consistent protection for legacy Windows and Linux servers
- Replacing ineffective legacy AV with the lightweight Traps agent created noticeable performance increases with VDI devices; zero signatures or DAT files
- Lower TCO: EndPoint Armor’s 24×7 ongoing support and management provides agent upgrades, profile & policy maintenance, consulting and problem resolution for IT team.
